Reduced T-dependent humoral immunity in CD20-deficient mice

Journal of Immunology

Volumn 191, Issue 6, 2013, Pages 3112-3118

  El Deen Morsy, Deyaa ^a   Sanyal, Ratna ^a   Zaiss, Anne K ^b,c   Deo, Rucha ^a   Muruve, Dan A ^b   Deans, Julie P ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CALCIUM; CD20 ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN FUNCTION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL STIMULATION; CONTROLLED STUDY; GERMINAL CENTER; HUMORAL IMMUNE DEFICIENCY; IN VITRO STUDY; INTRACELLULAR SIGNALING; MOUSE; NEWBORN; NONHUMAN; PARVOVIRUS INFECTION; PRIORITY JOURNAL; SHEEP ERYTHROCYTE; T LYMPHOCYTE; UPREGULATION;

ANIMALS; ANTIGENS, CD20; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNITY, HUMORAL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; T-LYMPHOCYTES;

EID: 84884255688     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202098     Document Type: Article

References (22)

1. Ishibashi, K., M. Suzuki, S. Sasaki, and M. Imai. 2001. Identification of a new multigene four-transmembrane family (MS4A) related to CD20, HTm4 and beta subunit of the high-affinity IgE receptor. Gene 264: 87-93.
2. Liang, Y., and T. F. Tedder. 2001. Identification of a CD20-, FcepsilonRIbeta-, and HTm4-related gene family: sixteen new MS4A family members expressed in human and mouse. Genomics 72: 119-127.
3. Cragg, M. S., C. A. Walshe, A. O. Ivanov, and M. J. Glennie. 2005. The biology of CD20 and its potential as a target for mAb therapy. Curr. Dir. Autoimmun. 8: 140-174.
4. Edwards, J. C., and G. Cambridge. 2006. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat. Rev. Immunol. 6: 394-403.
5. Rastetter, W., A. Molina, and C. A. White. 2004. Rituximab: expanding role in therapy for lymphomas and autoimmune diseases. Annu. Rev. Med. 55: 477-503.
6. Li, H., L. M. Ayer, J. Lytton, and J. P. Deans. 2003. Store-operated cation entry mediated by CD20 in membrane rafts. J. Biol. Chem. 278: 42427-42434.
7. Polyak, M. J., H. Li, N. Shariat, and J. P. Deans. 2008. CD20 homo-oligomers physically associate with the B cell antigen receptor. Dissociation upon receptor engagement and recruitment of phosphoproteins and calmodulin-binding proteins. J. Biol. Chem. 283: 18545-18552.
8. Kuijpers, T. W., R. J. Bende, P. A. Baars, A. Grummels, I. A. Derks, K. M. Dolman, T. Beaumont, T. F. Tedder, C. J. van Noesel, E. Eldering, and R. A. van Lier. 2010. CD20 deficiency in humans results in impaired T cellindependent antibody responses. J. Clin. Invest. 120: 214-222.
9. Uchida, J., Y. Lee, M. Hasegawa, Y. Liang, A. Bradney, J. A. Oliver, K. Bowen, D. A. Steeber, K. M. Haas, J. C. Poe, and T. F. Tedder. 2004. Mouse CD20 expression and function. Int. Immunol. 16: 119-129.
10. Bubien, J. K., L. J. Zhou, P. D. Bell, R. A. Frizzell, and T. F. Tedder. 1993. Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes. J. Cell Biol. 121: 1121-1132.
11. Kanzaki, M., M. A. Lindorfer, J. C. Garrison, and I. Kojima. 1997. Activation of the calcium-permeable cation channel CD20 by a subunits of the Gi protein. J. Biol. Chem. 272: 14733-14739.
12. O'Keefe, T. L., G. T. Williams, S. L. Davies, and M. S. Neuberger. 1998. Mice carrying a CD20 gene disruption. Immunogenetics 48: 125-132.
13. Zaiss, A. K., M. J. Cotter, L. R. White, S. A. Clark, N. C. Wong, V. M. Holers, J. S. Bartlett, and D. A. Muruve. 2008. Complement is an essential component of the immune response to adeno-associated virus vectors. J. Virol. 82: 2727-2740.
14. Ladics, G. S. 2007. Use of SRBC antibody responses for immunotoxicity testing. Methods 41: 9-19.
15. Zaiss, A. K., and D. A. Muruve. 2008. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge. Gene Ther. 15: 808-816.
16. Chirmule, N., W. Xiao, A. Truneh, M. A. Schnell, J. V. Hughes, P. Zoltick, and J. M. Wilson. 2000. Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J. Virol. 74: 2420-2425.
17. Xiao, W., N. Chirmule, M. A. Schnell, J. Tazelaar, J. V. Hughes, and J. M. Wilson. 2000. Route of administration determines induction of T-cellindependent humoral responses to adeno-associated virus vectors. Mol. Ther. 1: 323-329.
18. Testi, R., J. H. Phillips, and L. L. Lanier. 1989. T cell activation via Leu-23 (CD69). J. Immunol. 143: 1123-1128.
19. Taylor-Fishwick, D. A., and J. N. Siegel. 1995. Raf-1 provides a dominant but not exclusive signal for the induction of CD69 expression on T cells. Eur. J. Immunol. 25: 3215-3221.
20. Kwakkenbos, M. J., S. A. Diehl, E. Yasuda, A. Q. Bakker, C. M. van Geelen, M. V. Lukens, G. M. van Bleek, M. N. Widjojoatmodjo, W. M. Bogers, H. Mei, et al. 2010. Generation of stable monoclonal antibody-producing B cell receptorpositive human memory B cells by genetic programming. Nat. Med. 16: 123-128.
21. Anolik, J., R. J. Looney, A. Bottaro, I. Sanz, and F. Young. 2003. Downregulation of CD20 on B cells upon CD40 activation. Eur. J. Immunol. 33: 2398-2409.
22. Léveillé, C., R. AL-Daccak, and W. Mourad. 1999. CD20 is physically and functionally coupled to MHC class II and CD40 on human B cell lines. Eur. J. Immunol. 29: 65-74.